Publications
- Komentář ke studii2023 | First Faculty of Medicine
- CheckMate 9LA trial: commentary and clinical case report of patient with cerebellar metastasis2023 | First Faculty of Medicine
- Cemiplimab: monotherapy and combination therapy of NSCLC - analysis of locally advanced disease2023 | First Faculty of Medicine
- Immunotherapy associated pulmonary toxicity: pneumonitis2023 | First Faculty of Medicine
- Indikace durvalumabu v léčbě pacientů s bronchogenním karcinomem2023 | First Faculty of Medicine
- Ground-breaking ADAURA trial - osimertinib as adjuvant therapy of EGFR-mutated NSCLC2022 | First Faculty of Medicine
- Nivolumab as second-line therapy for patients with advanced NSCLC (non-small cell lung cancer)2022 | First Faculty of Medicine
- Tříleté výsledky studie CheckMate 9LA: komentář ke studii a klinická zkušenost2022 | First Faculty of Medicine
- Clinical experience with durvalumab treatment2021 | First Faculty of Medicine
- Chemoimmunotherapy in the treatment of ES-SCLC2021 | First Faculty of Medicine
Loading network view...